Company: PHAT
Filing Date: 2025-03-06
Form Type: 10-K
Source: 0000950170-25-034183
Chunk: 298

Company: Phathom Pharmaceuticals, Inc.
Filing Date: 2025-03-06
Form: 10-K
Item: Item 1B
Chunk 298
---
-2019
     
    10.12

    10.11#
     
    Employment Letter Agreement, dated August 29, 2019, by and between Terrie Curran and the Registrant
     
    S-1
     
    9-30-2019
     
    10.14

    10.12†
     
    Amendment No. 1 to Takeda License Agreement, dated September 21, 2020
     
    10-K
     
    3-30-2021
     
    10.20

    10.13†
     
    Supply and Packaging Services Agreement, by and between Sandoz GmbH and the Registrant, dated December 30, 2020
     
    10-K
     
    3-30-2021
     
    10.21

    10.14†
     
    Commercial Supply Agreement with Catalent Pharma Solutions, LLC entered into on July 2, 2021
     
    10-Q
     
    8-10-2021
     
    10.4

    10.15
     
    Loan and Security Agreement, dated September 17, 2021, by and among Hercules Capital and the Registrant
     
    10-Q
     
    11-8-2021
     
    10.1

    10.16†
     
    First Amendment to the Supply and Packaging Services Agreement, by and between Sandoz GmbH and the Registrant, dated December 4, 2021
     
    10-K
     
    3-1-2022
     
    10.30

    10.17#
     
    Employment Letter Agreement, dated March 22, 2022, by and between Molly Henderson and the Company
     
    10-Q
     
    5-10-2022
     
    10.1

    10.18# 
     
    Form of Restricted Stock Unit Grant Notice and Restricted Stock Unit Agreement under Phathom Pharmaceuticals, Inc. 2019 Equity Incentive Plan
     
    10-Q
     
    8-1-2022
     
    10.2

    10.19†
     
    Revenue Interest Financing Agreement, dated